These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 14713131)

  • 21. The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage.
    Yoo SJ; Cho B; Lee D; Son G; Lee YB; Soo Han H; Kim E; Moon C; Moon C
    Cell Death Dis; 2017 Aug; 8(8):e3003. PubMed ID: 28817120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
    Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
    J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells.
    Weishaupt JH; Rohde G; Pölking E; Siren AL; Ehrenreich H; Bähr M
    Invest Ophthalmol Vis Sci; 2004 May; 45(5):1514-22. PubMed ID: 15111610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nasal route as a potential pathway for delivery of erythropoietin in the treatment of acute ischemic stroke in humans.
    Garcia-Rodriguez JC; Sosa-Teste I
    ScientificWorldJournal; 2009 Sep; 9():970-81. PubMed ID: 19768354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin.
    Wiessner C; Allegrini PR; Ekatodramis D; Jewell UR; Stallmach T; Gassmann M
    J Cereb Blood Flow Metab; 2001 Jul; 21(7):857-64. PubMed ID: 11435798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system.
    Sirén AL; Fasshauer T; Bartels C; Ehrenreich H
    Neurotherapeutics; 2009 Jan; 6(1):108-27. PubMed ID: 19110203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential neuroprotective properties of endogenous and exogenous erythropoietin in a mouse model of traumatic brain injury.
    Shein NA; Grigoriadis N; Alexandrovich AG; Simeonidou C; Spandou E; Tsenter J; Yatsiv I; Horowitz M; Shohami E
    J Neurotrauma; 2008 Feb; 25(2):112-23. PubMed ID: 18260794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietin activates the phosporylated cAMP [adenosine 3'5' cyclic monophosphate] response element-binding protein pathway and attenuates delayed paraplegia after ischemia-reperfusion injury.
    Mares JM; Foley LS; Bell MT; Bennett DT; Freeman KA; Meng X; Weyant MJ; Cleveland JC; Fullerton DA; Puskas F; Reece TB
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):920-4. PubMed ID: 25500291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pretreatment with erythropoietin attenuates the neurological injury after spinal cord ischemia.
    Hwang J; Huh J; Kim J; Jeon Y; Cho S; Han S
    Spinal Cord; 2012 Mar; 50(3):208-12. PubMed ID: 22124347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guinea pig serum erythropoietin (EPO) selectively stimulates guinea pig erythroid progenitors: human or mouse erythroid progenitors do not form erythroid burst-forming unit colonies in response to guinea pig serum EPO.
    Stopka T; Zivny JH; Goldwasser E; Prchal JF; Necas E; Prchal JT
    Exp Hematol; 1998 Aug; 26(9):910-4. PubMed ID: 9694513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats.
    Sola A; Rogido M; Lee BH; Genetta T; Wen TC
    Pediatr Res; 2005 Apr; 57(4):481-7. PubMed ID: 15718373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythropoietin biology in cancer.
    Hardee ME; Arcasoy MO; Blackwell KL; Kirkpatrick JP; Dewhirst MW
    Clin Cancer Res; 2006 Jan; 12(2):332-9. PubMed ID: 16428469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin: new horizon in cardiovascular medicine.
    Koul D; Dhar S; Chen-Scarabelli C; Guglin M; Scarabelli TM
    Recent Pat Cardiovasc Drug Discov; 2007 Jan; 2(1):5-12. PubMed ID: 18221097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
    Arcasoy MO; Karayal AF
    Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulated endogenous erythropoietin/erythropoietin receptor system and exogenous erythropoietin rescue retinal ganglion cells after chronic ocular hypertension.
    Fu QL; Wu W; Wang H; Li X; Lee VW; So KF
    Cell Mol Neurobiol; 2008 Feb; 28(2):317-29. PubMed ID: 17554621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin and normal brain development: receptor expression determines multi-tissue response.
    Chen ZY; Warin R; Noguchi CT
    Neurodegener Dis; 2006; 3(1-2):68-75. PubMed ID: 16909040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin promotes spinal cord-derived neural progenitor cell proliferation by regulating cell cycle.
    Wang Y; Yao M; Zhou C; Dong D; Jiang Y; Wei G; Cui X
    Neuroscience; 2010 May; 167(3):750-7. PubMed ID: 20167254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythropoietin deficiency decreases vascular stability in mice.
    Chen J; Connor KM; Aderman CM; Smith LE
    J Clin Invest; 2008 Feb; 118(2):526-33. PubMed ID: 18219389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin and the brain: from neurodevelopment to neuroprotection.
    Buemi M; Cavallaro E; Floccari F; Sturiale A; Aloisi C; Trimarchi M; Grasso G; Corica F; Frisina N
    Clin Sci (Lond); 2002 Sep; 103(3):275-82. PubMed ID: 12193153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of erythropoietin on brain function.
    Jelkmann W
    Curr Pharm Biotechnol; 2005 Feb; 6(1):65-79. PubMed ID: 15727557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.